Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Carcinoma Infiltrating Duct

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Press Releases About Carcinoma Infiltrating Duct:

BioPortfolio Logo
Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase I/II Trial Results in Advanced Solid Cancers with a Focus on the Head and Neck at the AACR-NCI-EORTC Meeting 17th November, 2009 Oncolytics Biotech Inc.
CALGARY, Nov. 17 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ:ONCY) ("Oncolytics" or the "Company") today announced updated results from a Phase I/II U.K.
Oncolytics Biotech(R) Inc. Collaborators to Present Updated Phase I/II Trial Results in Advanced Solid Cancers with a Focus on the Head and Neck at the AACR-NCI-EORTC Meeting 16th November, 2009 Oncolytics Biotech Inc.
CALGARY, Nov. 16 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ:ONCY) ("Oncolytics" or the "Company") today announced that a poster presentation covering updated
Bayer and Onyx Announce Nexavar Data Presentations at 60th American Association for the Study of Liver Diseases Annual Meeting 29th October, 2009 Onyx Pharmaceuticals, Inc.
-- Late Breaker #9 First-in-men Demonstration of Sorafenib Plus TACE for the Treatment of Advanced Hepatocellular Carcinoma (SOCRATES trial) -- Dr. Andreas Erhardt, Klinik fur
Jennerex, Inc. Receives EMEA Orphan Drug Designation for JX-594 for the Treatment of Hepatocellular Carcinoma 19th October, 2009 Jennerex, Inc.
SAN FRANCISCO, Oct. 19 /PRNewswire/ -- Jennerex, Inc. (San Francisco, CA and Ottawa, Ontario), a clinical stage biotherapeutics company developing a proprietary breakthrough product class of targeted
AEterna Zentaris Partner, Keryx, Presented Updated Phase 2 Data on Perifosine (KRX-0401) for the Treatment of Advanced Metastatic Renal Cell Carcinoma at 8th International Kidney Cancer Symposium in Chicago 29th September, 2009 AETERNA ZENTARIS INC.
Perifosine Continues to Demonstrate Impressive Efficacy, Safety and Tolerability in Metastatic Renal Cell Carcinoma Patients who Progressed after Failing Treatment with both a VEGF

BioNews Results for Carcinoma Infiltrating Duct:

RSS Logo
BioPortfolio Logo
Types, treatments of breast cancer vary
Press Democrat:  Oct 24 2009 5:48PM Matching: carcinoma infiltrating duct

Carcinoma Infiltrating Duct Patents:

USPTO Logo
US Patent No.Title
7429650 Methods and compositions in breast cancer diagnosis and therapeutics
7419785 Methods and compositions in breast cancer diagnosis and therapeutics
7332281 Therapeutic targets in cancer
6821732 Methods and compositions in breast cancer diagnosis and therapeutics

BioPortfolio Ltd. offers e-mail and postal lists for Carcinoma Infiltrating Duct scientists - we have details of around 0 individuals working on Carcinoma Infiltrating Duct .


This page has been viewed 270 times
Recent Search Terms used to find this page: infiltrating duct | carcinoma in duc | examples of infiltrating ductal carcinomas | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Carcinoma Infiltrating Duct across BioPortfolio, or for Carcinoma Infiltrating Duct Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.